Actavis Ptc Ehf competitive analysis

Explore patent oppositions filed by Actavis Ptc Ehf against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISFeb 22, 2016
Methods For Concomitant Treatment Of Theophylline And FebuxostatTAKEDA PHARMACEUTICALS USAAug 11, 2015

Latest PTAB cases involving Actavis Ptc Ehf

Discover the latest PTAB cases involving Actavis Ptc Ehf, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Actavis Ptc Ehf with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACTAVIS PTC EHF2 - - -
NOVARTIS12555 - 21
TAKEDA PHARMACEUTICALS USA - 6 - -